21 recruiting, 19 completed, 19 unknown, 4 not yet recruiting. 72 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 72 | Recruiting 21, Completed 19, Unknown 19, Not yet recruiting 4, Withdrawn 4, Active not recruiting 3, Enrolling by invitation 1, Terminated 1 |
Follow chemotherapy: new trials by email Literature Review of chemotherapy trials Research Report on chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer Acupuncture, sham acupuncture - Lung Cancer (NSCLC), Immune Checkpoint Blockade | Not applicable | Recruiting | West China Hospital | 82 | 2026-08-31 | 2026-09-02 |
| Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer Carbon ion external beam radiotherapy plus 3 courses of three-dimensional brachytherapy. - Uterine Cervical Neoplasms | Not applicable | Recruiting | Zhejiang Cancer Hospital | 30 | 2026-07-01 | 2026-07-14 |
| HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocarcinoma IRE+chemotherapy, chemotherapy - IRE | Not applicable | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 60 | 2026-04-01 | 2026-08-31 |
| Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial Biospecimen Collection, Chemotherapy, Computed Tomography - Ewing Sarcoma, Round Cell Sarcoma With EWSR1-non-ETS Fusion | Not applicable | Recruiting | Mayo Clinic | 170 | 2025-12-05 | 2026-10-06 |
| Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis HistoSonics Edison® System, Chemotherapy - Colorectal Cancer, Liver Metastases | Not applicable | Recruiting | Case Comprehensive Cancer Center | 100 | 2025-11-19 | 2026-09-15 |
| Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes Trastuzumab, Pertuzumab, Chemotherapy - Breast Cancer | Not applicable | Not yet recruiting | Shandong Cancer Hospital and Institute | 1039 | 2025-09-30 | 2025-09-23 |
| A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial Chemotherapy, Computed Tomography, Internet-Based Intervention - Glioma, Recurrent Glioma | Not applicable | Recruiting | Mayo Clinic | 202 | 2025-09-12 | 2026-08-10 |
| XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer XH001, Chemotherapy - Pancreatic Cancer | Not applicable | Not yet recruiting | Peking Union Medical College Hospital | 12 | 2025-08-18 | 2025-08-11 |
| Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery Acupuncture, Sham Acupuncture, Chemotherapy - Gastric Cancer | Not applicable | Not yet recruiting | Guangzhou University of Traditional Chinese Medicine | 346 | 2025-08-01 | 2025-08-01 |
| Contact Radiotherapy for Rectal Cancer Radiotherapy, Short-course radiotherapy, Contact x-ray brachytherapy - Rectal Cancer | Not applicable | Recruiting | Alexander Valdman | 110 | 2025-03-03 | 2026-08-10 |
| Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. carbon ion radiotherapy (CIRT) - Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable | Not applicable | Recruiting | Gansu Wuwei Tumor Hospital | 62 | 2025-03-01 | 2025-03-25 |
| Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer Chemotherapy + vitamin D2, Chemotherapy - Vitamin D, Chemotherapy | Not applicable | Recruiting | Jiuda Zhao | 100 | 2024-12-01 | 2025-01-17 |
| Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma Stereotactic Body Radiation Therapy (SBRT), Chemotherapy - Non-metastasized Unresectable Pancreatic Carcinoma | Not applicable | Recruiting | Cancer Research Antwerp | 160 | 2024-07-19 | 2025-08-08 |
| XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer XH001, Ipilimumab Injection, Sintilimab injection - Pancreatic Cancer | Not applicable | Recruiting | Wu Wenming | 28 | 2024-03-12 | 2026-02-13 |
| Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity N-Acetylcysteine, Chemotherapy - Drug Toxicity | Not applicable | Unknown | Foundation University Islamabad | 70 | 2023-08-09 | 2023-08-31 |
| Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study Hypofractionated Image guided External Beam Radiation Therapy (EBRT), Cisplatin, Vaginal brachytherapy - Cervical Cancer, Endometrial Cancer | Not applicable | Recruiting | Tata Memorial Centre | 90 | 2023-05-29 | 2025-04-15 |
| PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy - Small Cell Lung Cancer Limited Stage | Not applicable | Unknown | Zhejiang Cancer Hospital | 220 | 2023-01-01 | 2023-12-19 |
| Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer Thermal Ablation, Chemotherapy - Pancreatic Ductal Adenocarcinoma | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 60 | 2023-01-01 | 2022-11-10 |
| Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer Chemotherapy - Cancer | Not applicable | Unknown | Bnai Zion Medical Center | 38 | 2022-11-15 | 2024-05-14 |
| Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy - Stage III Non-small Cell Lung Cancer | Not applicable | Withdrawn | Varian, a Siemens Healthineers Company | 2022-10-20 | 2026-02-05 |
Showing 20 of 72. Sign in to see all of them.
Breast Neoplasms (10) · Carcinoma, Non-Small-Cell Lung (9) · Colorectal Neoplasms (6) · Pancreatic Neoplasms (5) · Lung Neoplasms (4) · Rectal Neoplasms (3) · Anemia, Refractory, with Excess of Blasts (2) · Drug-Related Side Effects and Adverse Reactions (2) · Esophageal Neoplasms (2) · Esophageal Squamous Cell Carcinoma (2) · Glioblastoma (2) · Glioma (2) · Leukemia, Myeloid, Acute (2) · Lymphoma, T-Cell, Peripheral (2) · Ovarian Neoplasms (2)
The First Affiliated Hospital with Nanjing Medical University (3) · University of Washington (3) · Changhai Hospital (2) · Guangzhou University of Traditional Chinese Medicine (2) · Mayo Clinic (2) · Women's Hospital School Of Medicine Zhejiang University (2) · Yantai Yuhuangding Hospital (2) · Zhejiang Cancer Hospital (2) · Abramson Cancer Center at Penn Medicine (1) · Alexander Valdman (1) · Alliance for Clinical Trials in Oncology (1) · Azienda Ospedaliera di Padova (1) · Bnai Zion Medical Center (1) · CHU de Reims (1) · Cancer Research Antwerp (1)
China (26) · United States (19) · Italy (4) · Belgium (3) · Brazil (1) · Canada (1) · Czechia (1) · Egypt (1) · France (1) · Germany (1) · India (1) · Israel (1) · Norway (1) · Pakistan (1) · Poland (1)
Pamela Becker (2) · Peiwen Lian, PhD (2) · Abed Agbarya, MD (1) · Andrew McDonald, MD (1) · Bryan F. Meyers, MD, MPH (1) · Chukwumere E. Nwogu, MD (1) · Clare Peckitt (1) · Clinton Yam (1) · David Maloney (1) · Dennis Stanley, PhD (1) · Dhruv Singh (1) · Dr. Prachi D Mittal, MD (1) · Eli Estey (1) · Fabienne Lebrun, MD (1)
PMID 10813118, PMID 17882490, PMID 18640307, PMID 23187748, PMID 24007627, PMID 24423462, PMID 25674536, PMID 25761491, PMID 26118437, PMID 30286724, PMID 32499241, PMID 34251540, PMID 34253579, PMID 34952000, PMID 35507014, PMID 35914239, PMID 36038164, PMID 37505106, PMID 37547448, PMID 38159938, PMID 38484209, PMID 38597399, PMID 38897584, PMID 39503605, PMID 39558017, PMID 40204311, PMID 40471270, PMID 40769176, PMID 41152283, PMID 41168707, PMID 42093035, PMID 42687919
P30CA015704 (3), P30CA016672 (1), R01CA258997 (1)